About Filtricine
Stanford scientists founded Filtricine after discovering a revolutionary way to starve cancer cells without harming the rest of the body.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Venture Round
Global Headquarters
Santa Clara, United States
Tracked Since
Oct 11, 2026
Web & Domain Identity
Official Website
filtricine.com
Domain Registered Date
Nov 15, 2017
Social & Network Presence
LinkedIn Corporate
Company Profile
Company Milestones & Timeline
- Milestone
X account created (@filtricine)
168 followers
- Milestone
Website domain registered
filtricine.com
Investors & Backers
Berkeley Catalyst Fund (BCF)
Bluestein Ventures
Boutique Venture Partners
Evolution VC Partners
IndieBio
Sand Hill Angels
SOSV
SOSV SF & NY (Fka IndieBio)
True Ventures
Funding History
Venture Round
· Undisclosed
Backers: Berkeley Catalyst Fund (BCF), Bluestein Ventures, Boutique Venture Partners, Evolution VC Partners, IndieBio, Sand Hill Angels, SOSV, SOSV SF & NY (Fka IndieBio), True Ventures
Undisclosed Source
Founders & Leadership
Doug Kawahara
Consultant of Business Development
Work email & phone locked
Unlock →
Grace Xiaolu Yang
Co-founder
Work email & phone locked
Unlock →
John Chant
Chief Executive Officer
Work email & phone locked
Unlock →
Mike Partsuf
Senior Food Scientist
Work email & phone locked
Unlock →
Xiaodong Yang
Research Manager
Work email & phone locked
Unlock →
Xin Wang
Founder
Work email & phone locked
Unlock →
Xiyan Li
Co-founder
Work email & phone locked
Unlock →
Zehui Li
Senior Scientist
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026